Professional Education

  • Bachelor of Science, Mumbai University (2011)
  • Doctor of Philosophy, University of Illinois at Urbana Champaign (2017)
  • Master of Science, Mumbai University (2011)

Stanford Advisors

  • Jin Li, Postdoctoral Faculty Sponsor


All Publications

  • ADAR1: A New Target for Immuno-oncology Therapy. Molecular cell Bhate, A., Sun, T., Li, J. B. 2019; 73 (5): 866–68


    Three recent studies by Ishizuka etal. (2019), Liu etal. (2019), and Gannon etal. (2018) show that deleting RNA editing enzyme ADAR1 could induce higher cell lethality and render tumor cells more vulnerable to immunotherapy, pinpointing ADAR1 as a new immuno-oncology target.

    View details for PubMedID 30849393

Latest information on COVID-19